Satovsky Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,315
Closed -$287K 75
2025
Q4
$287K Buy
5,315
+71
+1% +$3.42K 0.06% 53
2025
Q3
$237K Buy
5,244
+73
+1% +$3.41K 0.05% 56
2025
Q2
$239K Buy
5,171
+63
+1% +$3.09K 0.05% 50
2025
Q1
$312K Sell
5,108
-264
-5% -$15.4K 0.07% 38
2024
Q4
$304K Buy
5,372
+57
+1% +$3.19K 0.07% 33
2024
Q3
$275K Buy
5,315
+66
+1% +$3.1K 0.06% 37
2024
Q2
$218K Buy
5,249
+69
+1% +$3.09K 0.05% 46
2024
Q1
$281K Sell
5,180
-938
-15% -$47.8K 0.08% 33
2023
Q4
$314K Buy
6,118
+57
+0.9% +$2.99K 0.1% 31
2023
Q3
$352K Buy
6,061
+47
+0.8% +$2.88K 0.12% 28
2023
Q2
$385K Buy
6,014
+141
+2% +$9.46K 0.13% 28
2023
Q1
$407K Buy
5,873
+1,038
+21% +$73.2K 0.15% 26
2022
Q4
$348K Buy
4,835
+34
+0.7% +$2.56K 0.14% 26
2022
Q3
$341K Buy
4,801
+35
+0.7% +$2.54K 0.2% 23
2022
Q2
$367K Buy
4,766
+33
+0.7% +$2.51K 0.21% 22
2022
Q1
$346K Buy
4,733
+39
+0.8% +$2.62K 0.23% 23
2021
Q4
$293K Buy
4,694
+40
+0.9% +$2.35K 0.2% 24
2021
Q3
$275K Buy
4,654
+33
+0.7% +$2.17K 0.21% 23
2021
Q2
$309K Buy
+4,621
New +$301K 0.24% 22

Other funds holding BMY

Satovsky Asset Management's BMY Position: Q1 2026 in Review

Satovsky Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 5,315 shares — an estimated $287K sold.

Satovsky Asset Management first reported a position in BMY in Q2 2021 and held it in 19 quarters. The position peaked at $407K in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Satovsky Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Satovsky Asset Management sold 5,315 Bristol-Myers Squibb shares in Q1 2026, an estimated $287K.
  • Satovsky Asset Management first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 19 quarters.
  • Satovsky Asset Management's Bristol-Myers Squibb position peaked at $407K in Q1 2023.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Satovsky Asset Management's 13F filing for Q1 2026, filed 14 May 2026.